Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloroplatinum (II)

[1]  G. Laurent,et al.  Light and electron microscopic characterization of the proliferative response induced by tobramycin in rat kidney cortex. , 1988, Experimental and molecular pathology.

[2]  G. Laurent,et al.  Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization. , 1988, Critical reviews in toxicology.

[3]  K. Kohn,et al.  DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone. , 1987, Cancer research.

[4]  N. Jaffe,et al.  Renal toxicity with cumulative doses of cis‐diamminedichloroplatinum‐II in pediatric patients with osteosarcoma. Effect on creatinine clearance and methotrexate excretion , 1987, Cancer.

[5]  P. Tyle,et al.  Biochemical Mechanisms of Platinum Antitumor Drugs , 1987 .

[6]  R. Safirstein,et al.  Cisplatin nephrotoxicity: insights into mechanism. , 1987, International journal of andrology.

[7]  P. Gill,et al.  Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Pathak.  Constitutional translocations and predisposition to T- and B-cell malignancies. , 1986, Cytogenetics and cell genetics.

[9]  G. Laurent,et al.  Tissue repair in rat kidney cortex after short treatment with aminoglycosides at low doses. A comparative biochemical and morphometric study. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[10]  G. Quamme,et al.  Long-term morphological and biochemical observations in cisplatin-induced hypomagnesemia in rats. , 1986, Nephron.

[11]  N. Vogelzang,et al.  Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin , 1985, Cancer.

[12]  G. Quamme,et al.  Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats. , 1985, Kidney international.

[13]  Williams Pd,et al.  Effect of cisplatin on organic ion transport in membrane vesicles from rat kidney cortex. , 1985 .

[14]  B. Trump,et al.  Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[15]  G. Laurent,et al.  Gentamicin-induced stimulation of DNA synthesis in rat kidney. Comparison between in vivo and in vitro models. , 1984, Toxicology letters.

[16]  P. Loehrer,et al.  Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.

[17]  G. Laurent,et al.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats , 1983, Antimicrobial Agents and Chemotherapy.

[18]  N. Mulder,et al.  Some effects of combination chemotherapy with cis‐platinum on renal function in patients with nonseminomatous testicular carcinoma , 1983, Cancer.

[19]  R. Schilsky,et al.  Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer. , 1982, Cancer treatment reports.

[20]  R. Weiss,et al.  The renal toxicity of cancer chemotherapeutic agents. , 1982, Cancer treatment reviews.

[21]  J. Kaufman,et al.  Cis-diamminedichlorplatinum-induced acute renal failure in the rat. , 1982, Kidney international.

[22]  C. Litterst.  Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration. , 1981, Toxicology and applied pharmacology.

[23]  J. Bond,et al.  cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. , 1981, Toxicology and applied pharmacology.

[24]  E. Walker,et al.  Methods of reduction of cisplatin nephrotoxicity. , 1981, Annals of clinical and laboratory science.

[25]  R. Bulger,et al.  Cyst formation in rat kidney induced by cis-platinum administration. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[26]  A. Prestayko.  9 – CISPLATIN AND ANALOGUES: A NEW CLASS OF ANTICANCER DRUGS , 1981 .

[27]  M. Weiner,et al.  Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. , 1980, The Journal of pharmacology and experimental therapeutics.

[28]  M. Weiner,et al.  Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys. , 1980, The Journal of pharmacology and experimental therapeutics.

[29]  L. Einhorn,et al.  Long term effect of Cis‐Diamminedichloride platinum (CDDP) on renal function and structure in man , 1978, Cancer.

[30]  S. Sternberg,et al.  The renal pathology in clinical trials of Cis‐platinum (II) diamminedichloride , 1977, Cancer.

[31]  R. Golbey,et al.  High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis , 1977, Cancer.

[32]  J. Ward,et al.  The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats. , 1976, Toxicology and applied pharmacology.

[33]  D. Houghton,et al.  A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. , 1976, The American journal of pathology.

[34]  F. Cuppage,et al.  Cell cycle studies in the regenerating rat nephron following injury with mercuric chloride. , 1972, Laboratory investigation; a journal of technical methods and pathology.

[35]  F. Cuppage,et al.  Repair of the nephron following injury with mercuric chloride. , 1967, The American journal of pathology.

[36]  H. Munro.  The determination of nucleic acids. , 2006, Methods of biochemical analysis.

[37]  K. Burton.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. , 1956, The Biochemical journal.

[38]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .